SUMITOMO LIFE INSURANCE CO has opened a new $7.6M position in $KKR, per a new SEC 13F filing. This disclosure reflects the funds' holdings for the 06-30-2025 report period. You can see the fund's full portfolio on Quiver Quantitative, and also track the largest institutional owners of $KKR.
$KKR Hedge Fund Activity
We have seen 657 institutional investors add shares of $KKR stock to their portfolio, and 621 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CAPITAL WORLD INVESTORS removed 7,590,092 shares (-40.2%) from their portfolio in Q1 2025, for an estimated $877,490,536
- CAPITAL INTERNATIONAL INVESTORS removed 6,472,790 shares (-18.4%) from their portfolio in Q1 2025, for an estimated $748,319,251
- JPMORGAN CHASE & CO removed 4,036,186 shares (-19.7%) from their portfolio in Q1 2025, for an estimated $466,623,463
- AMUNDI added 2,439,505 shares (+114.2%) to their portfolio in Q1 2025, for an estimated $282,031,173
- MASSACHUSETTS FINANCIAL SERVICES CO /MA/ added 2,391,434 shares (+14.3%) to their portfolio in Q1 2025, for an estimated $276,473,684
- GQG PARTNERS LLC removed 2,202,368 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $254,615,764
- GOLDMAN SACHS GROUP INC added 2,074,497 shares (+69.0%) to their portfolio in Q1 2025, for an estimated $239,832,598
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$KKR Insider Trading Activity
$KKR insiders have traded $KKR stock on the open market 5 times in the past 6 months. Of those trades, 2 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $KKR stock by insiders over the last 6 months:
- HENRY R KRAVIS (Co-Executive Chairman) has made 0 purchases and 2 sales selling 1,281,394 shares for an estimated $153,755,830.
- GEORGE R ROBERTS (Co-Executive Chairman) sold 1,190,094 shares for an estimated $142,573,261
- TIMOTHY R BARAKETT purchased 35,000 shares for an estimated $4,127,319
- ROBERT W SCULLY purchased 13,250 shares for an estimated $1,503,733
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$KKR Government Contracts
We have seen $1,193,196 of award payments to $KKR over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- GMP MANUFACTURING OF CDC FLUSC2 MULTIPLEX EUAAND IVD KITS: $763,453
- PCR TESTING KITS: $249,997
- BIOSEARCH BPA 499 YERSONIA PESTIS, 4 PER KIT: $116,780
- DLO-FB1-2 DUAL-LABELED PROBE, 5' FAM/3': $62,965
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
$KKR Congressional Stock Trading
Members of Congress have traded $KKR stock 6 times in the past 6 months. Of those trades, 1 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $KKR stock by members of Congress over the last 6 months:
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. purchased up to $15,000 on 05/07.
- REPRESENTATIVE JOSH GOTTHEIMER has traded it 4 times. They made 0 purchases and 4 sales worth up to $60,000 on 04/21, 04/14, 02/27, 02/26.
- REPRESENTATIVE ROBERT BRESNAHAN sold up to $15,000 on 04/08.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$KKR Analyst Ratings
Wall Street analysts have issued reports on $KKR in the last several months. We have seen 11 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Citigroup issued a "Buy" rating on 08/01/2025
- Oppenheimer issued a "Outperform" rating on 07/14/2025
- Wells Fargo issued a "Overweight" rating on 07/11/2025
- Barclays issued a "Overweight" rating on 07/10/2025
- Piper Sandler issued a "Overweight" rating on 06/30/2025
- Morgan Stanley issued a "Overweight" rating on 05/14/2025
- Keefe, Bruyette & Woods issued a "Outperform" rating on 05/02/2025
To track analyst ratings and price targets for $KKR, check out Quiver Quantitative's $KKR forecast page.
$KKR Price Targets
Multiple analysts have issued price targets for $KKR recently. We have seen 14 analysts offer price targets for $KKR in the last 6 months, with a median target of $150.0.
Here are some recent targets:
- Benjamin Budish from Barclays set a target price of $165.0 on 08/04/2025
- Kyle Voigt from Keefe, Bruyette & Woods set a target price of $162.0 on 08/04/2025
- Christopher Allen from Citigroup set a target price of $170.0 on 08/01/2025
- Chris Kotowski from Oppenheimer set a target price of $162.0 on 07/14/2025
- Brian Fitzgerald from JMP Securities set a target price of $150.0 on 07/14/2025
- Michael Brown from Wells Fargo set a target price of $156.0 on 07/11/2025
- Glenn Schorr from Evercore ISI Group set a target price of $150.0 on 07/10/2025
Note that there may be inaccuracies in these estimates due to filing errors by the funds, parsing errors by us, or other anomalies.
Check out Quiver Quantitative's $KKR ticker page for more data.
